US 10604806
Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers
granted A61KA61K31/44A61P
Quick answer
US patent 10604806 (Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers) held by Transgenion—International Institute for Regenerative Translational Medicine GmbH expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Transgenion—International Institute for Regenerative Translational Medicine GmbH
- Grant date
- Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/44, A61P, A61P11/00, A61P11/16